Summary of elevated complaint investigation (ecinv) (b)(4) for mdr 3005248192-2015-00013 follow-up report 1: the investigation included review of customer-supplied images, inspection of abbott molecular (am) retention samples from the lots in question, review of device history records, and review of capa and complaint report records.Related manufacturing and test records were reviewed, and no errors were identified.The manufacturing process is a manual process.Slides are 100% inspected at the manufacturing stage for specific issues including damage.Once placed into kits, the kits are sampled and inspected by quality control (qc).No issues were noted.In addition, a process is in place to minimize damage during shipment of slides from am.Review of the customer-supplied images did show damaged slides.Visual inspection of the qc retention samples from each lot in question (quantity: 3 slides per lot) showed no signs of damage.Other than the two complaints being addressed by this investigation (each complaint logged against a different lot of slides), there have been no other reports of broken slides in the past 12 months.One capa related to broken slides was identified.This capa was opened proactively as a result of management review to make improvements in three areas to minimize the potential for broken slides.The capa was resolved in january 2014.The current complaint rate for broken slides is 0.2% (there were 2 complaints for broken slides for 10,197 units sold), which indicates that the issue may be seen with a frequency of "occasional." no systemic product deficiency has been identified.(b)(4).
|